196 related articles for article (PubMed ID: 23895495)
1. Allogeneic murine mesenchymal stem cells: migration to inflamed joints in vivo and amelioration of collagen induced arthritis when transduced to express CTLA4Ig.
Sullivan C; Barry F; Ritter T; O'Flatharta C; Howard L; Shaw G; Anegon I; Murphy M
Stem Cells Dev; 2013 Dec; 22(24):3203-13. PubMed ID: 23895495
[TBL] [Abstract][Full Text] [Related]
2. Genetic mismatch affects the immunosuppressive properties of mesenchymal stem cells in vitro and their ability to influence the course of collagen-induced arthritis.
Sullivan C; Murphy JM; Griffin MD; Porter RM; Evans CH; O'Flatharta C; Shaw G; Barry F
Arthritis Res Ther; 2012 Jul; 14(4):R167. PubMed ID: 22812502
[TBL] [Abstract][Full Text] [Related]
3. IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints.
Chu CQ; Song Z; Mayton L; Wu B; Wooley PH
Ann Rheum Dis; 2003 Oct; 62(10):983-90. PubMed ID: 12972478
[TBL] [Abstract][Full Text] [Related]
4. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis.
Djouad F; Fritz V; Apparailly F; Louis-Plence P; Bony C; Sany J; Jorgensen C; Noël D
Arthritis Rheum; 2005 May; 52(5):1595-603. PubMed ID: 15880818
[TBL] [Abstract][Full Text] [Related]
5. Self in vivo production of a synthetic biological drug CTLA4Ig using a minicircle vector.
Rim YA; Yi H; Kim Y; Park N; Jung H; Kim J; Jung SM; Park SH; Ju JH
Sci Rep; 2014 Nov; 4():6935. PubMed ID: 25374010
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis.
Liu Y; Mu R; Wang S; Long L; Liu X; Li R; Sun J; Guo J; Zhang X; Guo J; Yu P; Li C; Liu X; Huang Z; Wang D; Li H; Gu Z; Liu B; Li Z
Arthritis Res Ther; 2010; 12(6):R210. PubMed ID: 21080925
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation.
Chen M; Su W; Lin X; Guo Z; Wang J; Zhang Q; Brand D; Ryffel B; Huang J; Liu Z; He X; Le AD; Zheng SG
Arthritis Rheum; 2013 May; 65(5):1181-93. PubMed ID: 23400582
[TBL] [Abstract][Full Text] [Related]
8. A crucial role for tumor necrosis factor receptor 1 in synovial lining cells and the reticuloendothelial system in mediating experimental arthritis.
Arntz OJ; Geurts J; Veenbergen S; Bennink MB; van den Brand BT; Abdollahi-Roodsaz S; van den Berg WB; van de Loo FA
Arthritis Res Ther; 2010; 12(2):R61. PubMed ID: 20370892
[TBL] [Abstract][Full Text] [Related]
9. Bone Marrow Mesenchymal Stem Cells Decrease the Expression of RANKL in Collagen-Induced Arthritis Rats via Reducing the Levels of IL-22.
Li F; Li X; Liu G; Gao C; Li X
J Immunol Res; 2019; 2019():8459281. PubMed ID: 31828174
[TBL] [Abstract][Full Text] [Related]
10. Trichostatin differentially regulates Th1 and Th2 responses and alleviates rheumatoid arthritis in mice.
Zhou X; Hua X; Ding X; Bian Y; Wang X
J Clin Immunol; 2011 Jun; 31(3):395-405. PubMed ID: 21305388
[TBL] [Abstract][Full Text] [Related]
11. Restricted expression of T cell receptor V beta and lymphokine genes in arthritic joints of a TCR V beta a (H-2q) mouse strain-BUB/BnJ-with collagen-induced arthritis.
Haqqi TM; Qu XM; Sy MS; Banerjee S
Autoimmunity; 1995; 20(3):163-70. PubMed ID: 7578877
[TBL] [Abstract][Full Text] [Related]
12. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis.
Augello A; Tasso R; Negrini SM; Cancedda R; Pennesi G
Arthritis Rheum; 2007 Apr; 56(4):1175-86. PubMed ID: 17393437
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis.
Quattrocchi E; Walmsley M; Browne K; Williams RO; Marinova-Mutafchieva L; Buurman W; Butler DM; Feldmann M
J Immunol; 1999 Jul; 163(2):1000-9. PubMed ID: 10395698
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory and osteogenic differentiation effects of mesenchymal stem cells by adenovirus-mediated coexpression of CTLA4Ig and BMP2.
Zhang X; Zhang C; Tang T; Qu Z; Lou J; Dai K
J Orthop Res; 2008 Mar; 26(3):314-21. PubMed ID: 17960657
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of long-interval repeated intravenous administration of human umbilical cord blood-derived mesenchymal stem cells in DBA/1 mice with collagen-induced arthritis.
Yu Y; Yoon KA; Kang TW; Jeon HJ; Sim YB; Choe SH; Baek SY; Lee S; Seo KW; Kang KS
J Tissue Eng Regen Med; 2019 Jul; 13(7):1134-1142. PubMed ID: 30959558
[TBL] [Abstract][Full Text] [Related]
16. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
17. Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis.
Schurgers E; Kelchtermans H; Mitera T; Geboes L; Matthys P
Arthritis Res Ther; 2010; 12(1):R31. PubMed ID: 20175883
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice.
Choi JJ; Yoo SA; Park SJ; Kang YJ; Kim WU; Oh IH; Cho CS
Clin Exp Immunol; 2008 Aug; 153(2):269-76. PubMed ID: 18713142
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T lymphocyte antigen 4 immunoglobulin modified dendritic cells attenuate allergic airway inflammation and hyperresponsiveness by regulating the development of T helper type 1 (Th1)/Th2 and Th2/regulatory T cell subsets in a murine model of asthma.
Ying L; Fu Z; Luo J; Zhou C; Chen Y; Wang L; Liu E
Clin Exp Immunol; 2011 Jul; 165(1):130-9. PubMed ID: 21545583
[TBL] [Abstract][Full Text] [Related]
20. C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice.
Banda NK; Tomlinson S; Scheinman RI; Ho N; Ramirez JR; Mehta G; Wang G; Vu VP; Simberg D; Kulik L; Holers VM
Front Immunol; 2020; 11():575154. PubMed ID: 33178202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
